Graves’ disease is caused by an immune system malfunction in which your body produces antibodies that overstimulate the thyroid gland. These antibodies mimic the normal hormone signal that tells your thyroid to produce hormones, but unlike the real signal, they don’t shut off. The result is a thyroid gland stuck in overdrive, flooding your body with excess thyroid hormones. With an annual incidence of 30 to 50 per 100,000 people, it’s the most common cause of hyperthyroidism, and it strikes women far more often than men.
But the deeper question is why the immune system starts making these antibodies in the first place. The answer involves a collision of genetics, hormonal shifts, infections, stress, and environmental exposures. Rarely does a single factor act alone.
The Core Malfunction: Antibodies That Mimic a Hormone
Your thyroid gland has receptors on its surface designed to receive a signal from the pituitary gland, a hormone called TSH. When TSH docks onto these receptors, the thyroid produces hormones that regulate your metabolism, heart rate, and body temperature. In Graves’ disease, the immune system creates antibodies (called TSH receptor antibodies) that bind to those same receptors and trigger the exact same response. The thyroid can’t tell the difference between the real hormone and the imposter antibody, so it keeps churning out thyroid hormones far beyond what the body needs.
These stimulating antibodies don’t just trigger hormone production. They also promote thyroid cell growth and survival, which is why many people with Graves’ disease develop an enlarged thyroid (goiter). The antibodies activate the same internal cell signaling pathways that TSH does, essentially hijacking the gland’s normal growth and function controls. Interestingly, not all thyroid receptor antibodies behave the same way. Some stimulate the thyroid, some block it, and some can even cause thyroid cell death. In Graves’ disease, the stimulating type dominates.
Genetic Susceptibility
Graves’ disease runs in families, and researchers have identified several gene variants that raise risk. None of these genes directly cause the disease, but they create an immune system that’s more prone to attacking the thyroid.
One of the strongest genetic links involves a group of genes called HLA, which control how your immune cells identify threats. A specific variant common in people of European descent changes the shape of a protein pocket on immune cells, potentially making it easier for those cells to mistakenly recognize thyroid tissue as foreign. Another important gene, CTLA-4, acts as a brake on immune cell activity. Variants that reduce this gene’s expression weaken that brake, allowing immune cells to multiply more aggressively than they should.
A variant in the PTPN22 gene has a similar effect. This gene normally helps suppress immune cell signaling, but the disease-linked version produces a protein that can’t properly perform its inhibitory role, leaving immune responses unchecked. Perhaps the most direct genetic connection involves the gene for the TSH receptor itself. This receptor is normally expressed at low levels in the thymus, where developing immune cells learn to tolerate the body’s own tissues. People carrying certain variants of this gene have lower thymus expression, meaning some immune cells that would normally be trained to ignore the TSH receptor escape into circulation and later attack it.
Other genes linked to Graves’ disease include CD40, which drives the interaction between immune cells that ultimately produces antibodies, and BACH2, which is essential for normal immune cell maturation. Variants in these genes can tip the balance toward an overactive antibody response.
Infections and Molecular Mimicry
One of the more compelling explanations for why the immune system starts targeting the thyroid involves a case of mistaken identity. Certain bacteria carry proteins on their surface that structurally resemble the TSH receptor. When the immune system builds antibodies to fight the infection, some of those antibodies happen to cross-react with the thyroid.
Research has identified a specific mechanism involving Yersinia enterocolitica, a bacterium that causes food-borne gastrointestinal infections. This bacterium has outer membrane proteins (porins) that are structurally similar enough to the TSH receptor that antibodies made against the bacteria also bind to the thyroid receptor. In laboratory studies, thyroid-stimulating antibodies taken from Graves’ patients recognized these bacterial proteins, and the early precursor versions of those antibodies did too. The proposed sequence is that the initial immune response to the bacterial infection expands a population of B cells, which then undergo further mutations over time until some of them produce antibodies that stimulate the thyroid. This provides a concrete pathway from a common gut infection to an autoimmune thyroid disease, at least in genetically susceptible people.
Stress as a Trigger
Major psychological stress has long been recognized as a trigger for Graves’ disease, and the mechanism involves how stress hormones reshape immune function. During prolonged stress, your body releases elevated levels of cortisol, adrenaline, and inflammatory signaling molecules. While cortisol at high therapeutic doses suppresses the immune system, the lower levels produced naturally during stress appear to have a different, more disruptive effect. They shift the balance of immune activity in ways that can hyperactivate certain immune pathways rather than calm them down.
Clinical observations support this connection. Case reports document patients developing Graves’ disease during periods of intense stress, then experiencing spontaneous improvement after the stressor was removed, suggesting that stress relief can help restore normal immune regulation. Stress doesn’t cause Graves’ disease on its own, but in someone with the right genetic background, it can be the push that tips the immune system into attacking the thyroid.
Postpartum Immune Rebound
Pregnancy creates a unique immunological situation. To prevent the body from rejecting the fetus, the immune system shifts toward a more tolerant mode during gestation. After delivery, it snaps back, often overshooting into a more aggressive state. This rebound is why the postpartum period is a well-known trigger for several autoimmune diseases, Graves’ disease among them.
The shift involves a swing from one type of immune response back to another, combined with a disruption in the regulatory immune cells that normally keep autoimmunity in check. For women who are genetically predisposed, this temporary immune dysregulation after delivery can be enough to trigger the production of thyroid-stimulating antibodies. Researchers view the postpartum period as a precipitating event rather than a root cause: it doesn’t create susceptibility, but it can unmask it. Once the immune system settles back to its pre-pregnancy balance, some women achieve remission on their own.
Why Women Are Affected More Often
The 4-to-1 female-to-male ratio in Graves’ disease points to sex hormones as a contributing factor. Before puberty, boys and girls develop the disease at roughly equal rates. The gap appears after puberty, which implicates estrogen.
Women with hyperthyroidism tend to have estrogen levels two to three times higher than normal, while progesterone levels run lower. This hormonal imbalance creates an inflammatory environment that may amplify the autoimmune process. Estrogen influences the immune system in complex ways that depend on its concentration, the type of estrogen receptor involved, and the tissue in question. In the context of Graves’ disease, elevated estrogen appears to increase the expression of certain growth factor receptors on orbital and thyroid tissue, potentially intensifying the inflammatory response that drives both thyroid overactivity and the eye disease that sometimes accompanies it.
Smoking and the Risk of Eye Disease
Smoking is one of the clearest modifiable risk factors. Data from the Nurses’ Health Study, which tracked over 100,000 women, found that current smokers had roughly double the risk of developing Graves’ disease compared to women who had never smoked. The risk increased with the number of pack-years: women who had smoked more than 25 pack-years had nearly twice the risk of never-smokers.
The good news is that quitting makes a measurable difference. Women who had stopped smoking more than 15 years earlier had about half the risk of current smokers. Past smokers overall had a lower risk than current smokers, though their risk remained slightly elevated compared to people who had never smoked. Smoking is also the strongest known risk factor for Graves’ eye disease, the swelling and bulging of the eyes that develops in some patients. If you’ve been diagnosed with Graves’ disease and still smoke, quitting is one of the most impactful steps you can take.
Excess Iodine Intake
Iodine is essential for thyroid hormone production, but too much can backfire. Normally, when the thyroid encounters a sudden surge of iodine, it temporarily dials down hormone production as a safety mechanism. In people with underlying thyroid abnormalities, including those with dormant or mild Graves’ disease, this protective mechanism can fail. The thyroid instead uses the extra iodine to ramp up hormone production, a phenomenon known as the Jod-Basedow effect.
This is most commonly seen in people who have been living in iodine-deficient regions and are then suddenly exposed to higher iodine levels, for example through iodized salt programs or iodine-containing contrast dyes used in medical imaging. It can also occur in people with Graves’ disease who have been treated with antithyroid medications and then encounter a large iodine load. Excess iodine doesn’t initiate the autoimmune process, but in a thyroid that’s already primed by Graves’ antibodies, it can trigger or worsen hyperthyroidism.
How These Factors Work Together
Graves’ disease almost never results from a single cause. The typical pattern involves a person who inherits several immune-related gene variants that create a susceptible foundation. On top of that genetic baseline, one or more triggers push the immune system past its tipping point. That trigger might be a bacterial infection that generates cross-reactive antibodies, a period of severe emotional stress, the hormonal upheaval after childbirth, or years of cigarette smoking. Often, multiple triggers overlap. A genetically susceptible woman who smokes, goes through a stressful period, and has recently given birth faces a significantly compounded risk.
Understanding these layers explains why the disease can seem to appear out of nowhere. The genetic susceptibility may have been present since birth, quietly waiting for the right combination of environmental and hormonal circumstances to set it off.